XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 19.81%7.09B | 12.97%1.67B | 23.17%1.81B | 21.62%1.82B | 21.50%1.79B | 8.19%5.92B | 14.73%1.48B | 15.45%1.47B | 8.18%1.49B | -3.42%1.47B |
Operating revenue | 19.81%7.09B | 12.97%1.67B | 23.17%1.81B | 21.62%1.82B | 21.50%1.79B | 8.19%5.92B | 14.73%1.48B | 15.45%1.47B | 8.18%1.49B | -3.42%1.47B |
Cost of revenue | 15.29%1.95B | 18.05%497M | 24.27%512M | 10.09%469M | 9.11%467M | 4.59%1.69B | 2.68%421M | 4.83%412M | 8.40%426M | 2.64%428M |
Gross profit | 21.61%5.14B | 10.95%1.18B | 22.74%1.3B | 26.22%1.35B | 26.58%1.32B | 9.70%4.23B | 20.34%1.06B | 20.18%1.06B | 8.10%1.07B | -5.70%1.04B |
Operating expense | 8.03%2.17B | 5.71%555M | 8.84%542M | 9.45%556M | 8.23%513M | 7.91%2.01B | 6.71%525M | 6.41%498M | 13.14%508M | 5.57%474M |
Selling and administrative expenses | 6.31%1.74B | 3.27%442M | 7.69%434M | 7.47%446M | 6.99%413M | 6.88%1.63B | 6.20%428M | 4.68%403M | 12.77%415M | 4.04%386M |
-General and administrative expense | ---- | ---- | ---- | 7.47%446M | 6.99%413M | 6.88%1.63B | ---- | ---- | 12.77%415M | 4.04%386M |
Depreciation amortization depletion | 15.55%431M | 16.49%113M | 13.68%108M | 18.28%110M | 13.64%100M | 12.69%373M | 8.99%97M | 14.46%95M | 14.81%93M | 12.82%88M |
-Depreciation and amortization | 15.55%431M | 16.49%113M | 13.68%108M | 18.28%110M | 13.64%100M | 12.69%373M | 8.99%97M | 14.46%95M | 14.81%93M | 12.82%88M |
Operating profit | 33.86%2.98B | 16.10%620M | 35.05%759M | 41.43%792M | 41.90%806M | 11.37%2.22B | 37.63%534M | 35.75%562M | 3.90%560M | -13.41%568M |
Net non-operating interest income expense | 5.58%-237M | 21.21%-52M | 9.09%-60M | 11.27%-63M | -29.17%-62M | -8.66%-251M | -1.54%-66M | -13.79%-66M | -29.09%-71M | 9.43%-48M |
Non-operating interest income | 43.66%102M | 70.59%29M | 47.37%28M | 53.33%23M | -21.43%22M | 373.33%71M | 183.33%17M | 280.00%19M | 650.00%15M | 1,300.00%28M |
Non-operating interest expense | 5.28%339M | -2.41%81M | 3.53%88M | 0.00%86M | 10.53%84M | 30.89%322M | 16.90%83M | 34.92%85M | 50.88%86M | 38.18%76M |
Other net income (expense) | -7.89%-41M | -138.89%-43M | 144.44%4M | -433.33%-10M | 157.14%8M | -533.33%-38M | -550.00%-18M | -136.00%-9M | 107.32%3M | -333.33%-14M |
Gain on sale of security | 181.25%13M | 300.00%8M | 100.00%4M | --1M | ---- | 33.33%-16M | -50.00%2M | -80.00%2M | ---- | ---21M |
Earnings from equity interest | 15.79%22M | -28.57%5M | 66.67%15M | 100.00%2M | --0 | 11.76%19M | 133.33%7M | -10.00%9M | -50.00%1M | 0.00%2M |
Special income (charges) | -17.24%-102M | -63.89%-59M | 22.22%-21M | -70.00%-17M | 64.29%-5M | -97.73%-87M | -200.00%-36M | -2,600.00%-27M | 67.74%-10M | ---14M |
-Less:Restructuring and merger&acquisition | 17.24%102M | 63.89%59M | -22.22%21M | 70.00%17M | -64.29%5M | -23.68%87M | -56.10%36M | 2,600.00%27M | -67.74%10M | --14M |
Other non- operating income (expenses) | -43.48%26M | -66.67%3M | -14.29%6M | -66.67%4M | -31.58%13M | 2.22%46M | 0.00%9M | 16.67%7M | -36.84%12M | 375.00%19M |
Income before tax | 39.48%2.7B | 16.67%525M | 44.35%703M | 46.14%719M | 48.62%752M | 9.94%1.94B | 37.61%450M | 27.82%487M | 11.06%492M | -16.91%506M |
Income tax | 95.72%640M | 18.18%130M | 74.23%169M | 44.35%166M | 3,400.00%175M | -15.28%327M | 35.80%110M | 24.36%97M | -0.86%115M | -95.50%5M |
Net income | 28.05%2.06B | 16.18%395M | 36.92%534M | 46.68%553M | 15.17%577M | 17.03%1.61B | 38.21%340M | 28.71%390M | 15.29%377M | 0.60%501M |
Net income continuous Operations | 28.05%2.06B | 16.18%395M | 36.92%534M | 46.68%553M | 15.17%577M | 17.03%1.61B | 38.21%340M | 28.71%390M | 15.29%377M | 0.60%501M |
Minority interest income | 0.00%1M | 0 | 0 | 1M | 1M | 0 | 1M | 0 | ||
Net income attributable to the parent company | 28.06%2.06B | 16.18%395M | 37.28%534M | 46.42%552M | 15.17%577M | 16.96%1.61B | 38.21%340M | 28.38%389M | 15.29%377M | 0.60%501M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 28.06%2.06B | 16.18%395M | 37.28%534M | 46.42%552M | 15.17%577M | 16.96%1.61B | 38.21%340M | 28.38%389M | 15.29%377M | 0.60%501M |
Basic earnings per share | 29.08%11.32 | 17.20%2.18 | 38.68%2.94 | 47.80%3.03 | 15.75%3.16 | 17.40%8.77 | 38.81%1.86 | 28.48%2.12 | 15.17%2.05 | 1.49%2.73 |
Diluted earnings per share | 28.98%11.26 | 17.30%2.17 | 38.86%2.93 | 47.32%3.02 | 15.81%3.15 | 17.34%8.73 | 38.06%1.85 | 27.88%2.11 | 15.82%2.05 | 1.49%2.72 |
Dividend per share | 10.39%3.4 | 10.39%0.85 | 10.39%0.85 | 10.39%0.85 | 10.39%0.85 | 10.00%3.08 | 10.00%0.77 | 10.00%0.77 | 10.00%0.77 | 10.00%0.77 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |